These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
000-27205
|
56-2132396
|
|
(Commission File
No.)
|
(IRS Employer Identification
No.)
|
|
|
|
|
518 West C Street, Newton, North
Carolina
|
28658
|
|
(Address of Principal Executive
Offices)
|
(Zip Code)
|
|
Indicate by check
mark if the registrant is a well-known seasoned issuer, as defined
in Rule 405 of the Securities Act.
|
|
|
Yes
|
☐
|
|
No
|
☒
|
|
|
|
|
Yes
|
☐
|
|
No
|
☒
|
|
|
|
|
Yes
|
☒
|
|
No
|
☐
|
|
|
|
|
Yes
|
☒
|
|
No
|
☐
|
|
|
|
Large Accelerated
Filer
|
☐
|
|
Accelerated
Filer
|
☒
|
|
Non-Accelerated
Filer
|
☐
|
|
Smaller Reporting
Company
|
☐
|
|
|
Yes
|
☐
|
|
No
|
☒
|
|
|
|
PEOPLES BANCORP OF NORTH CAROLINA, INC.
|
||
|
FORM 10-K CROSS REFERENCE INDEX
|
||
|
|
||
|
|
2017
Form
10-K
|
Notice of
2018
Annual
Meeting,
Proxy
Statement
and
Annual Report
|
|
|
Page
|
Page
|
|
PART I
|
|
|
|
Item 1 -
Business
|
4 -
11
|
N/A
|
|
Item 1A -
Risk Factors
|
11 -
18
|
N/A
|
|
Item 1B -
Unresolved Staff Comments
|
18
|
N/A
|
|
Item 2 -
Properties
|
19
|
N/A
|
|
Item 3 -
Legal Proceedings
|
19
|
N/A
|
|
Item 4 -
Mine Safety Disclosures
|
19
|
N/A
|
|
|
|
|
|
PART II
|
|
|
|
Item 5 - Market for Registrant’s Common Equity, Related
Stockholder
Matters and Issuer Purchases of Equity
Securities
|
20 -
22
|
N/A
|
|
Item 6 -
Selected Financial Data
|
22
|
A-3
|
|
Item 7 - Management’s Discussion and Analysis of Financial
Condition and
Results of Operations
|
23
|
A-4 -
A-23
|
|
Item 7A -
Quantitative and Qualitative Disclosures About Market
Risk
|
23
|
A-22 -
A-23
|
|
Item 8 -
Financial Statements and Supplementary Data
|
23
|
A-24 -
A-66
|
|
Item 9 - Changes in and Disagreements with Accountants on
Accounting
and Financial Disclosure
|
23
|
N/A
|
|
Item 9A -
Controls and Procedures
|
23 -
24
|
N/A
|
|
Item 9B -
Other Information
|
24
|
N/A
|
|
|
|
|
|
PART III
|
|
|
|
Item 10 -
Directors and Executive Officers and Corporate
Governance
|
24
|
A-67
|
|
Item 11 -
Executive Compensation
|
24
|
14 -
24
|
|
Item 12 - Security Ownership of Certain Beneficial Owners and
Management
and Related Stockholder
Matters
|
24 -
25
|
5 -
7
|
|
Item 13 - Certain Relationships and Related Transactions
and
Director Independence
|
25
|
11 and
27
|
|
Item 14 -
Principal Accountant Fees and Services
|
25
|
30
|
|
|
|
|
|
PART IV
|
|
|
|
Item 15 -
Exhibits and Financial Statement Schedules
|
26 -
29
|
N/A
|
|
|
|
|
|
Signatures
|
30
|
N/A
|
|
Owned
Corporate
Office
518 West C
Street
Newton, North Carolina
28658
420 West A
Street
Newton, North Carolina
28658
2619 North Main
Avenue
Newton, North Carolina
28658
213 1st Street,
West
Conover, North Carolina
28613
3261 East Main
Street
Claremont, North Carolina
28610
6125 Highway 16
South
Denver, North Carolina
28037
5153 N.C. Highway
90E
Hiddenite, North Carolina
28636
200 Island Ford
Road
Maiden, North Carolina
28650
3310 Springs Road
NE
Hickory, North Carolina
28601
142 South Highway
16
Denver, North Carolina
28037
106 North Main
Street
Catawba, North Carolina
28609
2050 Catawba Valley
Boulevard
Hickory, North Carolina
28601
800 E. Arrowood
Road
Charlotte, North Carolina
28217
1074 River
Highway
Mooresville, North Carolina
28117
|
Leased
1333 2nd Street
NE
Hickory, North Carolina
28601
1910 East Main
Street
Lincolnton, North Carolina
28092
760 Highway 27
West
Lincolnton, North Carolina
28092
102 Leonard
Avenue
Newton, North Carolina
28658
6350 South
Boulevard
Charlotte, North Carolina
28217
4451 Central
Avenue
Suite A
Charlotte, North Carolina
28205
3752/3754 Highway 16
North
Denver, North Carolina
28037
9624-I Bailey
Road
Cornelius, North Carolina
28031
3023-10 Capital
Boulevard
Raleigh, North Carolina
27604
2530 Meridian
Parkway
Durham, North Carolina
27713
|
|
|
|
|
Cash Dividend
|
|
2017
|
Low Bid
|
High Bid
|
Per Share
|
|
First
Quarter
|
$
20.38
|
28.54
|
0.11
|
|
|
|
|
|
|
Second
Quarter
|
$
19.65
|
29.91
|
0.11
|
|
|
|
|
|
|
Third
Quarter
|
$
26.00
|
36.12
|
0.11
|
|
|
|
|
|
|
Fourth
Quarter
|
$
27.73
|
34.55
|
0.11
|
|
|
|
|
Cash Dividend
|
|
2016
|
Low Bid
|
High Bid
|
Per Share
|
|
First
Quarter
|
$
16.62
|
17.59
|
0.07
|
|
|
|
|
|
|
Second
Quarter
|
$
16.74
|
18.05
|
0.09
|
|
|
|
|
|
|
Third
Quarter
|
$
17.51
|
20.70
|
0.09
|
|
|
|
|
|
|
Fourth
Quarter
|
$
18.00
|
24.45
|
0.09
|
|
|
Period Ending
|
|||||
|
Index
|
12/31/12
|
12/31/13
|
12/31/14
|
12/31/15
|
12/31/16
|
12/31/17
|
|
Peoples
Bancorp of North Carolina, Inc.
|
100.00
|
157.33
|
201.73
|
220.12
|
290.70
|
397.96
|
|
NASDAQ
Composite Index
|
100.00
|
140.12
|
160.78
|
171.97
|
187.22
|
242.71
|
|
SNL
Southeast Bank Index
|
100.00
|
135.52
|
152.63
|
150.24
|
199.45
|
246.72
|
|
|
|
|
|
|
|
|
|
Source: S&P Global Market Intelligence
|
|
|
|
|
|
|
|
© 2017
|
|
|
|
|
|
|
|
ISSUER PURCHASES OF EQUITY SECURITIES
|
|||||
|
|
|
|
|
|
|
|
Period
|
Total
Number
of
Shares
Purchased
|
|
Average
Price
Paid
per
Share
|
Total
Number
of
Shares
Purchased
as
Publicly
Announced
Plans
or
Programs
(2)
|
Maximum
Number
(or
Approximate
Dollar Value)
of
Shares that
May
Yet Be
Purchased
Under the Plans
or
Programs
(3)
|
|
|
|
|
|
|
|
|
January 1 - 31,
2017
|
1,113
|
|
$24.09
|
-
|
$16,180
|
|
|
|
|
|
|
|
|
February 1 - 28,
2017
|
-
|
|
-
|
-
|
$16,180
|
|
|
|
|
|
|
|
|
March 1 - 31,
2017
|
323
|
|
25.23
|
-
|
$16,180
|
|
|
|
|
|
|
|
|
April 1 - 30,
2017
|
639
|
|
27.40
|
-
|
$16,180
|
|
|
|
|
|
|
|
|
May 1 - 31,
2017
|
413
|
|
25.58
|
-
|
$16,180
|
|
|
|
|
|
|
|
|
June 1 - 30,
2017
|
-
|
|
-
|
-
|
$16,180
|
|
|
|
|
|
|
|
|
July 1 - 31,
2017
|
853
|
|
34.13
|
-
|
$16,180
|
|
|
|
|
|
|
|
|
August 1 - 31,
2017
|
-
|
|
-
|
-
|
$16,180
|
|
|
|
|
|
|
|
|
September 1 - 30,
2017
|
217
|
|
27.73
|
-
|
$16,180
|
|
|
|
|
|
|
|
|
October 1 - 31,
2017
|
669
|
|
30.87
|
-
|
$16,180
|
|
|
|
|
|
|
|
|
November 1 - 30,
2017
|
347
|
|
30.67
|
-
|
$16,180
|
|
|
|
|
|
|
|
|
December 1 - 31,
2017
|
-
|
|
-
|
-
|
$16,180
|
|
|
|
|
|
|
|
|
Total
|
4,574
|
(1)
|
$28.30
|
-
|
|
|
(1) The Company
purchased 4,574 shares on the open market in the year ended
December 31, 2017 for its deferred compensation plan. All purchases
were funded by participant contributions to the plan. Number
of shares purchased and average price paid per share have been
adjusted for the 10% stock dividend paid in December
2017.
|
|||||
|
|
|
|
|
|
|
|
(2) Reflects shares
purchased under the 2016 Stock Repurchase Plan authorized by the
Company's Board of Directors in 2016.
|
|||||
|
|
|
|
|
|
|
|
(3) Reflects dollar
value of shares that may yet be purchased under the Stock
Repurchase Plan authorized by the Company's Board of Directors in
2016.
|
|||||
|
Plan Category
|
Number of securities
to be issued upon
exercise of
outstanding option,
warrants and rights
(1), (2), (3)
|
Weighted-average
exercise price of
outstanding options,
warrants and rights
(4)
|
Number of securities remaining
available for future issuance under
equity compensation plans
(excluding securities reflected in
column (a)) (5), (6)
|
|
|
(a)
|
(b)
|
(c)
|
|
Equity
compensation plans
approved
by security holders
|
25,801
|
$
30.69
|
284,658
|
|
Equity
compensation plans not
approved
by security holders
|
-
|
-
|
-
|
|
Total
|
25,801
|
$
30.69
|
284,658
|
|
(1) Includes 16,583 restricted
stock units granted on February 19, 2015 (adjusted for the 10%
stock dividend paid December 15, 2017) under the Omnibus Plan.
These restricted stock grants vest on February 19,
2019.
|
|
|
|
(2) Includes 5,104 restricted
stock units granted on February 18, 2016 (adjusted for the 10%
stock dividend paid December 15, 2017) under the Omnibus Plan.
These restricted stock grants vest on February 20,
2020.
|
|
|
|
(3) Includes 4,144 restricted
stock units granted on March 1, 2017 (adjusted for the 10% stock
dividend paid December 15, 2017) under the Omnibus Plan. These
restricted stock grants vest on March 1, 2021.
|
|
|
|
(4) The exercise price used for
the grants of restricted stock units under the Omnibus Plan is
$30.69, the closing price for the Company’s stock on December
31, 2017.
|
|
|
|
(5) Reflects shares currently
reserved for possible issuance under the Omnibus Plan.
|
|
|
|
(6) Adjusted for the 10% stock
dividend paid December 15, 2017.
|
|
SIGNATURES
|
||||||
|
|
||||||
|
Pursuant to the requirements of Section 13 or
15(d) of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
|
|
PEOPLES BANCORP OF NORTH CAROLINA,
INC.
|
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Lance A.
Sellers
|
|
|
|
|
Lance A.
Sellers
|
|
|
|
|
President and Chief Executive
Officer
|
|
|
|
|
|
|
|
|
|
Date: March 15,
2018
|
|
|
Signature
|
|
Title
|
|
Date
|
||
|
|
|
|
|
|
||
|
/s/ Lance A.
Sellers
|
|
President and Chief Executive
Officer
|
|
March 15,
2018
|
||
|
Lance A.
Sellers
|
|
(Principal Executive
Officer)
|
|
|
||
|
|
|
|
|
|
||
|
/s/ James S.
Abernethy
|
|
Director
|
|
March 15,
2018
|
||
|
James S.
Abernethy
|
|
|
|
|
||
|
|
|
|
|
|
||
|
/s/ Robert C.
Abernethy
|
|
Chairman of the Board and
Director
|
|
March 15,
2018
|
||
|
Robert C.
Abernethy
|
|
|
|
|
||
|
|
|
|
|
|
||
|
/s/ Douglas S.
Howard
|
|
Director
|
|
March 15,
2018
|
||
|
Douglas S.
Howard
|
|
|
|
|
||
|
|
|
|
|
|
||
|
/s/ A. Joseph Lampron,
Jr.
|
|
Executive Vice President and
Chief
|
|
March 15,
2018
|
||
|
A. Joseph Lampron,
Jr.
|
|
Financial Officer (Principal
Financial
|
|
|
||
|
|
|
and Principal Accounting
Officer)
|
|
|
||
|
|
|
|
|
|
||
|
/s/ John W. Lineberger,
Jr.
|
|
Director
|
|
March 15,
2018
|
||
|
John W. Lineberger,
Jr.
|
|
|
|
|
||
|
|
|
|
|
|
||
|
/s/ Gary E.
Matthews
|
|
Director
|
|
March 15,
2018
|
||
|
Gary E.
Matthews
|
|
|
|
|
||
|
|
|
|
|
|
||
|
/s/ Billy L. Price, Jr.,
M.D.
|
|
Director
|
|
March 15,
2018
|
||
|
Billy L. Price, Jr.,
M.D.
|
|
|
|
|
||
|
|
|
|
|
|
||
|
/s/ Larry E.
Robinson
|
|
Director
|
|
March 15,
2018
|
||
|
Larry E.
Robinson
|
|
|
|
|
||
|
|
|
|
|
|
||
|
/s/ William Gregory
Terry
|
|
Director
|
|
March 15,
2018
|
||
|
William Gregory
Terry
|
|
|
|
|
||
|
|
|
|
|
|
||
|
/s/ Dan Ray Timmerman,
Sr.
|
|
Director
|
|
March 15,
2018
|
||
|
Dan Ray Timmerman,
Sr.
|
|
|
|
|
||
|
|
|
|
|
|
||
|
/s/ Benjamin I.
Zachary
|
|
Director
|
|
March 15,
2018
|
||
|
Benjamin I.
Zachary
|
|
|
|
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|